Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Portfolio
Trending News
More News >
News
Enterprise Solutions
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
CYTK
Stock Latest News
The Fly
Cytokinetics reiterated as top pick at H.C. Wainwright, Camzyos updates positive
1d ago
BMY
CYTK
Premium
Stock Analysis & Ideas
Patent Cliff Looms Large for Bristol-Myers Squibb Stock (BMY)
1d ago
BMY
CYTK
Premium
Ratings
Cytokinetics Hold Rating: Competitive Challenges and Market Dynamics
1d ago
CYTK
Premium
Weekend Updates
Insider Moves: Cytokinetics, Bj’s, Gran Tierra, PBF, Immunovant
3d ago
BJ
GTE
Premium
Ratings
Cytokinetics’ Market Challenges and Neutral Outlook Amid MAPLE Trial Anticipations
5d ago
CYTK
Premium
Ratings
Cytokinetics’ Aficamten: A Promising Opportunity Amidst nHCM Treatment Challenges
7d ago
CYTK
Premium
The Fly
Cytokinetics reiterated top pick after Bristol failure at H.C. Wainwright
7d ago
CYTK
Premium
The Fly
Cytokinetics price target lowered to $54 from $62 at BofA
7d ago
BMY
CYTK
Premium
Ratings
Cautious Outlook on Cytokinetics Amid CMI Market Challenges and Strategic Concerns
8d ago
CYTK
Premium
The Fly
Citi adds two, removes two from North America Focus List
8d ago
KO
HII
Premium
Ratings
Optimistic Buy Rating on Cytokinetics Driven by Promising Aficamten Trial Outcomes
13d ago
CYTK
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
18d ago
ABVC
CMPX
Premium
Ratings
Cytokinetics’ Aficamten Poised as Best-in-Class Cardiac Treatment with Favorable Risk-Benefit Profile
18d ago
CYTK
Premium
Ratings
Optimistic Buy Rating for Cytokinetics: Aficamten’s Market Potential Amidst Competition
19d ago
CYTK
Premium
Ratings
Cytokinetics: A Promising Investment with Aficamten’s Competitive Edge in HCM Treatment
20d ago
CYTK
Premium
Ratings
Cytokinetics Faces Long-term Competitive Threat from Edgewise’s Promising Cardiac Myosin Inhibitor Study
20d ago
CYTK
Premium
Ratings
Cytokinetics’ Aficamten: Promising Clinical Developments and Strategic Initiatives Drive Buy Rating
21d ago
CYTK
Premium
The Fly
Cytokinetics CEO Blum sells 15,000 common shares
22d ago
CYTK
Premium
The Fly
Cytokinetics announces launch of EARTH-HCM
1M ago
CYTK
Premium
Ratings
Promising Potential of Cytokinetics’ Aficamten in Cardiac Treatment Drives Buy Recommendation
1M ago
CYTK
Premium
The Fly
Cytokinetics’ data supports aficamten’s potential, says H.C. Wainwright
1M ago
CYTK
Premium
The Fly
Cytokinetics announces presentations as ACC Scientific Session & Expo
1M ago
CYTK
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
